- Author:
Shina LEE
1
;
Duk Hee KANG
Author Information
- Publication Type:Review
- Keywords: Blood group incompatibility; Kidney transplantation; Immunosuppression; Antibodies
- MeSH: Antibodies; Blood Group Incompatibility; Humans; Immunosuppression; Kidney; Kidney Failure, Chronic; Kidney Transplantation*; Tissue Donors
- From:The Ewha Medical Journal 2015;38(1):7-13
- CountryRepublic of Korea
- Language:Korean
- Abstract: Kidney transplantation is the best treatment for end-stage renal disease patients. However, the relative shortage of organs for transplantation has led to ABO-incompatible kidney transplantation as an accepted method to expand the pool of kidney donors. Recent advances in immunosuppression and antibody removal methods have made ABO-incompatible kidney transplantation more feasible, and have increased the opportunities for patients to receive kidney transplantation, as well as for special patients with ABO-compatible donor. Indeed, the outcome of ABO-incompatible kidney transplantation has shown remarkable developments and is now comparable to that of ABO-compatible kidney transplantation during last decade. However, there are still some uncertain issues to be addressed in ABO-incompatible kidney transplantation. In this article, we reviewed the current status and protocol of ABO-incompatible kidney transplantation and listed the concerns to be addressed in near future.